Use of bronchodilators during non-invasive mechanical ventilation

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 59, Issue 2, 2003, Pages 123-127

  Ceriana, P ^a   Navalesi, P ^a   Rampulla, C ^a   Prinianakis, G ^b   Nava, Stefano ^a  

^a IRCCS   (Italy)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; PLACEBO; SALBUTAMOL;

AEROSOL; AIRWAY OBSTRUCTION; ARTIFICIAL VENTILATION; BREATHING MUSCLE; CLINICAL TRIAL; COST CONTROL; DATA ANALYSIS; DISEASE EXACERBATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG PENETRATION; DRUG USE; DRUG WITHDRAWAL; HEALTH CARE COST; HUMAN; HYPERCAPNIA; LUNG GAS EXCHANGE; MEDICAL NEBULIZER; METERED DOSE INHALER; MUSCLE FATIGUE; RESPIRATION LOAD; REVIEW; SIDE EFFECT;

EID: 0242406705     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. ATS standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S78-S121.
2. The BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52 Suppl 5: S1-S28.
3. Poggi R, Brandolese R, Bernasconi M, Manzin E, Rossi A. Doxofylline and respiratory mechanics. Short-term effects in mechanically ventilated patients with airflow obstruction and respiratory failure. Chest 1989; 96: 772-778.
4. Rubini F, Rampulla C, Nava S. Acute effect of corticosteroids on respiratory mechanics in mechanically ventilated patients with chronic airflow obstruction and acute respiratory failure. Am J Respir Crit Care Med 1994; 149: 306-310.
5. Salmeron S, Brochard L, Mal H et al. Nebulized vs intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. Am J Respir Crit Care Med 1994; 149: 1466-1460.
6. Similowski T, Milic-Emili J, Derenne JP. Respiratory mechanics during acute respiratory failure of chronic obstructive pulmonary disease. In: Derenne JP, Whitelaw WA, Similowski T (eds) Acute Pulmonary Failure in Chronic Obstructive Pulmonary Disease. Marcel Deccer, New-York, 1996, pp 23-46.
7. Karpel JP. Bronchodilator response to anticholinergic and beta-adrenergic agents in acute and stable COPD. Chest 1991; 99: 871-876.
8. Niewoehner DE, Erbland ML, Deupree RH et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Eng J Med 1999; 340: 1941-1947.
9. Appendini L, Purro A, Patessio A et al. Partitioning of inspiratory muscle workload and pressure assistance in ventilator-dependent COPD patients. Am J Respir Crit Care Med 1996; 154: 1301-1309.
10. Mouloudi E, Katsanoulas K, Anastasaki M, Hoing S, Georgepoulos D. Bronchodilators delivery by metered-dose inhaler in mechanically ventilated COPD patients: Influence of tidal volume. Intensive Care Med 1999; 25: 1215-1221.
11. Bernasconi M, Brandolese R, Poggi R, Manzin E, Rossi A. Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic obstructive pulmonary disease. Intensive Care Med 1990; 16: 108-114.
12. Maesen BLP, Westermann CJJ, Duurkens VAM, Van Den Bosch JMM. Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 1103-1108.
13. Khoukaz G, Gross NJ. Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropium. Am J Respir Crit Care Med 1999; 160: 1028-1030.
14. Hess D, Fisher D, Williams P, Pooler S, Kacmarek RM. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 1996; 110 (2): 498-505.
15. Hess DR, Acosta FL, Ritz RH, Kacmarek RM, Camargo CA. The effect of heliox on nebulizer function using a beta-agonist bronchodilator. Chest 1999; 115: 184-9.
16. Turner MO, Gafni A, Swan D, Fitzgerald JM. A review and economic evaluation of bronchodilator delivery methods in hospitalized patients. Arch Intern Med 1996; 156: 2113-8.
17. Pavia D, Thomson ML, Clarke SW, Shannon II S. Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax 1977; 32: 194-197.
18. Palmes FD. Measurement of pulmonary air spaces using aerosol. Arch Intern Med 1973; 131: 76-79.
19. Newman SP, Pavia D, Moren F, Sheahan NF, Clarke SW. Deposition of pressurized aerosols in the human respiratory tract. Thorax 1981; 36: 52-55.
20. Dolovich MB, Sanchis J, Rossman C, Newhouse MT. Aerosol penetrance: A sensitive index of peripheral airways obstruction. J Appl Physiol 1976; 40: 468-471.
21. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291: 755-758.
22. Dhand R, Tobin M: Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med 1997; 156: 3-10.
23. Mouloudi E, Katsanoulas K, Anastasaki M, Hoing S, Georgopulos D. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: Influence of tidal volume. Intensive Care Med 1999; 25: 1215-21.
24. Mouloudi E, Katsanoulas K, Anastasaki M, Askitopoulou E, Georgopulos D. Bronchodilator delivery by metered dose inhaler in mechanically ventilated COPD patients: Influence of end-inspiratory pause. Eur Resp J 1998; 12: 165-9
25. 2 agonist induced bronchodilation in mechanically ventilated COPD patients. Intensive Care Med 2001; 27: 42-6
26. Good M, Fink JB, Dhand R, Tobin MJ. Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med 2001; 163: 109-114.
27. Dhand R, Duarte AG, Jurban A, Jenne JW, Fink JB et al. Dose-response to bronchodilator delivery by metered-dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med 1996; 154: 388-393.
28. Segal MS, Salomon A, Dulfano MJ, Herschfus JA. Intermittent positive pressure breathing; Its use in inspiratory phase of respiration. N Engl J Med 1954; 250: 225-7.
29. Shenfield GM, Evans ME, Walker SR, Paterson JW. The fate of nebulized salbutamol administered by intermittent positive pressure respiration to asthmatic patients. Am Rev Resp Dis 1973; 108: 501-505.
30. Dolovich MB, Killian D, Wolff RK, Obminski G, Newhouse MT. Pulmonary aerosol deposition in chronic bronchitis: Intermittent positive pressure breathing versus quiet breathing. Am Rev Resp Dis 1977; 115: 397-402.
31. Thomas SHL, Langford JA, George RJD, Geddes DM. Aerosol deposition in the human lung: Effect of high-frequency oscillation on the deposition characteristics of an inhaled nebulized aerosol. Clin Sci 1988; 75: 535-542.
32. Pollack CV, Fleisch KB, Dowsey K. Treatment of acute bronchospasm with b-adrenergic agonist aerosols delivered by a nasal bilevel positive airway pressure circuit. Ann Emerg Med 1995; 26: 552-557.
33. Appendini L, Patessio A, Zanaboni S et al. Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149: 1069-1076.
34. Parkes SN, Bersten AD. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Thorax 1997; 52: 171-175.
35. Nava S, Karakurt S, Rampulla C, Braschi A, Fanfulla F. Salbutamol delivery during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease: A randomized, controlled study. Int Care Med 2001; 27: 1627-35.
36. Faroux B, Itti E, Pigeot J et al. Optimization of aerosol deposition by pressure support in children with cystic fibrosis. Am J Respir Crit Care Med 2000; 162: 2265-71.
37. Chatmongkolchart S, Schettino GP, Dillman C, Kacmarek RMH. In vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: Effect of ventilator settings and nebulizer position. Crit Care Med 2002; Nov; 30 (11): 2515-9.